These discussions often center on everyday experiences with GLP-1 medications, including how dosing choices affect comfort, cost, and consistency
In November 2024, the Biden administration introduced a proposal to expand Medicare and Medicaid coverage of GLP-1s to treat obesity as a condition on its own, which would expand access for millions of beneficiaries
Neither in the presence of active colitis (without ileal involvement) nor in quiescent ileitis, EEC numbers were changed in the terminal ileum (154)
doi: 10.1016/j.celrep.2015.06.062 204 WangY
The three-way comparison between semaglutide, tirzepatide, and retatrutide consistently shows retatrutide at the top for total body weight percentage lost, and the difference becomes more pronounced at higher doses and longer treatment durations
Taking oral semaglutide with food or extra fluid can make it ineffective